Additionally, as discussed in the previous chapter, most, if not all, CMT-related TRPV4 mutants are gain-of-function mutations, and some of these mutants have been shown to enhance intracellular Ca2+, a mechanism similar to that of L619F. The gene discussed is TRPV4; the disease is Charcot-Marie-Tooth disease.